Back to Search Start Over

G protein–coupled receptor 21 in macrophages: An in vitro study.

Authors :
Bordano, Valentina
Kinsella, Gemma K.
Cannito, Stefania
Dianzani, Chiara
Gigliotti, Casimiro Luca
Stephens, John C.
Monge, Chiara
Bocca, Claudia
Rosa, Arianna C.
Miglio, Gianluca
Dianzani, Umberto
Findlay, John B.C.
Benetti, Elisa
Source :
European Journal of Pharmacology. Jul2022, Vol. 926, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

GPR21 is an orphan and constitutively active receptor belonging to the superfamily of G-Protein Coupled Receptors (GPCRs). GPR21 couples to the G q family of G proteins and is expressed in macrophages. Studies of GPR21 knock-out mice indicated that GPR21 may be involved in promoting macrophage migration. The aim of this study was to evaluate the role of GPR21 in human macrophages, analyzing (i) its involvement in cell migration and cytokine release and (ii) the consequence of its pharmacological inhibition by using the inverse agonist GRA2. THP-1 cells were activated and differentiated into either M 1 or M 2 macrophages. GPR21 expression was evaluated at gene and protein level, the signalling pathway was investigated by an IP 1 assay, and cytokine release by ELISA. Cell migration was detected by the Boyden chamber migration assay, performed on macrophages derived from both the THP-1 cell line and human peripheral blood monocytes. In addition, we compared the effect of the pharmacological inhibition of GPR21 with the effect of the treatment with a specific GPR21 siRNA to downregulate the receptor expression, thus confirming that GRA2 acts as an inverse agonist of GPR21. GRA2 does not affect cell viability at the tested concentrations, but significantly reduces the release of TNF-α and IL-1β from M 1 macrophages. The analysis of the migratory ability highlighted opposite effects of GRA2 on M 1 and M 2 macrophages since it decreased M 1 , while it promoted M 2 cell migration. Therefore, the pharmacological inhibition of GPR21 could be of interest for pathological conditions characterized by low grade chronic inflammation. [Display omitted] • GPR21 expression is higher in M 1 over M 2 macrophages derived from THP-1 cells. • A GPR21 inverse agonist, GRA2, reduces proinflammatory cytokine release. • GPR21 inhibition decreases migration of M 1 macrophages but induces that of M 2 cells. • GPR21 inhibition might reduce inflammation by modulating macrophage behaviour. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00142999
Volume :
926
Database :
Academic Search Index
Journal :
European Journal of Pharmacology
Publication Type :
Academic Journal
Accession number :
157149326
Full Text :
https://doi.org/10.1016/j.ejphar.2022.175018